MedTrace Logo

The Effect of Hyoscine-N-butylbromide (HBB, Buscopan) in Augmented Labour Among Primigravidae

NCT04349722 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 110

Last updated 2022-04-06

No results posted yet for this study

Summary

This study compares the duration of active phase of labour in women who received buscopan and those who don't.

Conditions

  • Labor Long

Interventions

DRUG

Hyoscine Butylbromide

Intervention is given once a participant is in established labor

OTHER

Placebo

Intervention is given once a participant is in established labor

Sponsors & Collaborators

  • National University of Malaysia

    lead OTHER

Principal Investigators

  • Aida Hani Mohd Kalok · National University Malaysia

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-12-01
Primary Completion
2020-06-30
Completion
2020-06-30

Countries

  • Malaysia

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04349722 on ClinicalTrials.gov